Trice Medical

Why Trice Medical?

Trice Medical was founded to fundamentally improve orthopedic diagnostics.

Trice has pioneered fully integrated camera-enabled technologies that provide a clinical solution that is optimized for the physicians’ office. Our mission is to provide more immediate and definitive patient care, eliminating the false reads associated with current indirect modalities and significantly reduce the overall cost to the healthcare system.

Trice Medical’s FDA-approved 510(k)-cleared device, mi-eye 2, is a handheld 2.2mm arthroscope, consisting of a needle with an integrated camera and a light source designed for in-office use. With mi-eye 2, physicians can provide real-time analysis, effect faster treatment, and schedule patients for surgery immediately—resulting in quicker outcomes for patients and a more efficient process for doctors.

Market Opportunity

Trice Medical’s addressable market opportunity is approximately $10 billion, including 32 million office visits for related knee and shoulder pain and more than 8 million MRIs performed annually in the U.S. alone.

Company Milestones

  • Trice Medical appoints Craig Carra as CFO
  • Trice Medical receives FDA 510(k) clearance for mi-eye 2
  • Trice Medical and Pacific Medicalannounce multi-state distribution agreement
  • Trice Medical Closes $19.3 Million Series C Financing To Address Increased Demand For Mi-Eye